AAOS releases revised clinical practice guideline for osteoarthritis of the knee

June 4, 2013

The American Academy of Orthopaedic Surgeons (AAOS) recently released its revised clinical practice guideline (CPG) on the treatment of osteoarthritis of the knee, addressing two key changes. Most of the remaining recommendations provided in the 2009 CPG go unchanged. CPGs are not meant to be stand-alone documents, but rather serve as a point of reference and educational tool for both primary care physicians and orthopaedic surgeons.

The original guideline, as well as this revised version, was developed to include only treatments which are less invasive than . Osteoarthritis (OA) is a common condition that can affect any joint in the body particularly after years of use. It is also known as "wear and tear" arthritis and most commonly occurs in people who are 65 years of age or older. Some 33 million Americans are affected by osteoarthritis, and it is the leading cause of .

The two primary changes recommended in the 2013 guidelines that differ from the 2009 CPG include:

  • Acetaminophen: The recommended dosage was reduced from 4,000 mg to 3,000 mg a day. This is not a change made by AAOS specifically for OA patients, but an overall change made by the FDA since 2009 for individuals who use acetaminophen.
  • Intra-articular Hyaluronic Acid (HA): Intra-articular hyaluronic acid is no longer recommended as a method of treatment for patients with symptomatic . The 2009 guidelines review was inconclusive regarding this treatment method.

"Fourteen studies assessed intra-articular hyaluronic acid injections," said David S. Jevsevar, MD, MBA, chair of the Committee on Evidence-Based Quality and Value which oversees the development of guidelines. "Although a few individual studies found statistically significant treatment effects, when combined together in a meta-analysis the evidence did not meet the minimum clinically important improvement thresholds."

Other important recommendations that remain in the revised guideline include:

  • Patients who only display symptoms of osteoarthritis and no other problems, such as loose bodies or meniscus tears, should not be treated with arthroscopic lavage.
  • Patients with a Body Mass Index (or BMI) greater than 25 should lose a minimum of five percent of their body weight.
  • Patients should begin or increase their participation in low-impact aerobic exercise.

"One of the best ways for a patient to reduce his or her pain and realize better health is to be proactive," said Dr. Jevsevar, who also is an orthopaedic surgeon in St. George, Utah. "For instance, if a patient is overweight, losing weight is probably the best thing he or she can do to slow the progression of osteoarthritis of the ."

The AAOS work group suggests that patients with symptomatic OA of the knee receive one of the following analgesics for pain (unless there are contraindications to this treatment):

  • Acetaminophen (not to exceed 3,000 mg per day)
  • For short-term pain relief, intra-articular corticosteroids
  • Non-steroidal anti inflammatory drugs (NSAIDs)

The AAOS work group cannot recommend the following treatments:

  • Custom made lateral wedge insoles
  • Glucosamine and/or chondroitin sulfate or hydrochloride
  • Needle lavage (aspiration of the joint with injection of saline)

In addition, although acupuncture continues to grow in popularity, the evidence did not support its use in patients with OA of the knee.

Due to a lack of available research, the CPG is unable to recommend for or against the use of bracing, growth factor injections and/or platelet rich plasma.

"There are many treatment options for of the knee," said Dr. Jevsevar. "However, not all are effective. There needs to be more and better testing, since results are still inconclusive. Therefore, if you are experiencing knee problems, the best advice is to work closely with your physician and orthopaedic surgeon to develop the best course of treatment for you."

Explore further: Study finds genetic risk factor for knee osteoarthritis

More information: The full guideline along with all supporting documentation and workgroup disclosures is available on the AAOS website: www.aaos.org/research/guidelin … /GuidelineOAKnee.asp

Related Stories

Study finds genetic risk factor for knee osteoarthritis

May 14, 2013
(Medical Xpress)—A newly published paper reports that individuals with radiographic knee osteoarthritis (OA) who had a specific pattern of gene variations in the interleukin-1 receptor antagonist gene (IL1RN), which is ...

Evidence insufficient to recommend routine antibiotics for joint replacement patients

December 18, 2012
The American Academy of Orthopaedic Surgeons (AAOS), and the American Dental Association (ADA) found that there is insufficient evidence to recommend the routine use of antibiotics for patients with orthopaedic implants to ...

Sugar injections for knee arthritis may ease pain

May 21, 2013
(HealthDay)—Injections of a sugar solution appear to help relieve knee pain and stiffness related to osteoarthritis, a new study suggests.

Nonsurgical treatment of osteoarthritis discussed

February 5, 2013
Osteoarthritis is a progressive joint disease that affects approximately one third of individuals age 65 and older. The disorder causes gradual loss of joint cartilage and bony degeneration while simultaneously creating new ...

Weight loss may prevent, treat osteoarthritis in obese patients

March 8, 2013
Weight loss may prevent and significantly alleviate the symptoms of osteoarthritis, a progressive disease of the joints known as "wear and tear" arthritis, according to a literature review appearing in the March 2013 issue ...

Knee replacement not an 'easy solution' for obese patients

October 24, 2012
Obese patients have a greater risk of complications following total knee replacement surgery, including post-surgical infections, according to a new literature review recently published in the Journal of Bone and Joint Surgery ...

Recommended for you

Fluid in the knee holds clues for why osteoarthritis is more common in females

June 26, 2017
Researchers have more evidence that males and females are different, this time in the fluid that helps protect the cartilage in their knee joints.

Biologics before triple therapy not cost effective for rheumatoid arthritis

May 29, 2017
Stepping up to biologic therapy when methotrexate monotherapy fails offers minimal incremental benefit over using a combination of drugs known as triple therapy, yet incurs large costs for treating rheumatoid arthritis (RA). ...

Drug for refractory psoriatic arthritis shows promise in clinical trial

May 24, 2017
In a pivotal phase-3 clinical trial led by a Stanford University School of Medicine investigator, patients with psoriatic arthritis for whom standard-of-care pharmaceutical treatments have provided no lasting relief experienced ...

Cross-species links identified for osteoarthritis

May 17, 2017
New research from the University of Liverpool, published today in the journal npj Systems Biology and Applications, has identified 'cell messages' that could help identify the early stages of osteoarthritis (OA).

Osteoarthritis could be prevented with good diet and exercise

May 12, 2017
Osteoarthritis can potentially be prevented with a good diet and regular exercise, a new expert review published in the Nature Reviews Rheumatology reports.

Rodents with trouble walking reveal potential treatment approach for most common joint disease

May 11, 2017
Maintaining the supply of a molecule that helps to nourish cartilage prevented osteoarthritis in animal models of the disease, according to a report published in Nature Communications online May 11.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.